Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub, our home for evidence-based coverage of GLP-1 therapies, weight-management protocols, and the genetics underneath them. Browse all Peptides & GLP-1 education
The following is an independent editorial review. PlexusDx has no commercial relationship with Brello or its parent company, and no affiliate links or compensation are involved.
People searching "Brello Ozempic" usually want to know one thing: can this program get them Ozempic, or something like it? The short answer requires unpacking what Ozempic actually is versus what a compounding-based telehealth program dispenses. This review draws that distinction and adds the genetic context most programs leave out. Fair-balance, as of April 2026.
Start a Semaglutide program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded Semaglutide, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider reviews your fit.
Start your intake →
Ozempic vs. what Brello actually dispenses
Ozempic is a brand name for semaglutide, an FDA-approved GLP-1 receptor agonist. A telehealth operator like Brello (Brello Health) may route a prescription to a retail pharmacy for an FDA-approved brand product, or to a 503A compounding pharmacy for compounded semaglutide — which is not the same as the branded product. Which pathway applies depends on eligibility and program design, detailed on Brello's own site.
Branded semaglutide and the compounded pathway
Semaglutide is the active molecule behind several branded GLP-1 products. Compounded semaglutide is prepared for individual patients by state-licensed 503A pharmacies and differs from FDA-approved manufacturing. The clinical evidence for semaglutide's weight-management effects comes largely from the STEP program (The New England Journal of Medicine, 2021); the tirzepatide comparison points, SURMOUNT (NEJM 2022) and SURMOUNT-OSA (NEJM 2024), sit alongside it. Endpoints and populations differ, and outcomes vary individually.
How a prescription decision gets made
The flow is consistent across telehealth GLP-1 programs: you submit an intake with weight, medical history, and medications; a licensed clinician reviews eligibility; a prescription issues if appropriate; it routes to a retail or 503A compounding pharmacy; and follow-up visits handle titration and side effects. Provider type, pharmacy partner, and subscription structure are where operators differ.
Cost drivers for semaglutide programs
Whether you receive a branded product or a compounded formulation is a major cost driver. Brello publishes pricing on its own site, and totals move with product, subscription tier, and dispensing pathway. Across the telehealth GLP-1 market, monthly spend as of April 2026 runs roughly $200 to $700 or more, with wide variance. Verify Brello's current pricing directly before committing.
The semaglutide biology genetics reveal
No telehealth intake reads the genetics that shape how semaglutide's pathway behaves in you. Variants in FTO (fat-mass and obesity-associated), GLP1R (the GLP-1 receptor gene — semaglutide's direct target), MC4R (a satiety-linked melanocortin receptor), and TCF7L2 (a glucose-homeostasis transcription factor) map your baseline metabolic terrain. They are pathway-level markers, not drug-response predictors — but they describe the biology any semaglutide prescription enters.
PlexusDx provides semaglutide and tirzepatide through its Weight Management Protocols — as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. The differentiator is the upstream step: the Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights — FTO, MC4R, and TCF7L2 among them — before a protocol begins. That is the test before you invest approach.
Not affiliated: PlexusDx is not affiliated with Brello and has no commercial relationship with the companies named in this article.
Related reading on PlexusDx: Ozempic Cost With Insurance, Ozempic Discount, Generic For Ozempic, Price Of Ozempic.
Disclaimer: This article is educational. PlexusDx is not affiliated with Brello and has no commercial relationship with the companies reviewed; it offers semaglutide and tirzepatide through its own Weight Management Protocols, and this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related pathways and does not predict response to any specific medication. Consult a qualified healthcare provider before starting any peptide protocol.
Compare the PlexusDx path: see the Weight Management Protocols for semaglutide and tirzepatide with genetic context, or begin with the Precision Peptide Genetic Test to understand your GLP-1 pathway first.
Frequently Asked Questions
Does Brello prescribe Ozempic?
Ozempic is a specific FDA-approved brand of semaglutide. A telehealth program may route to a retail pharmacy for an FDA-approved brand or to a 503A compounding pharmacy for compounded semaglutide, which is different from the branded product. Confirm on Brello's own site which options its clinicians can prescribe.
What is the difference between branded and compounded semaglutide?
Branded semaglutide is an FDA-approved product manufactured to that standard. Compounded semaglutide is prepared for individual patients by state-licensed 503A pharmacies and is not FDA-approved as a finished product. The two follow different regulatory pathways, and which you receive depends on the program and eligibility.
How does the Precision Peptide Genetic Test relate to semaglutide?
It does not predict how you will respond to semaglutide or any branded GLP-1. It analyzes pathway-level variants in FTO and MC4R, and TCF7L2 that shape baseline GLP-1 biology — the upstream context that applies regardless of which telehealth service prescribes the compound.
How does PlexusDx compare to Brello for semaglutide?
PlexusDx offers semaglutide through its Weight Management Protocols and pairs it with the Precision Peptide Genetic Test. The distinction is the added genetic layer: pathway-level insight before a protocol starts, which most telehealth-only programs such as Brello do not bundle with the medication.
Explore more in the PlexusDx Education Hub. Browse all Peptides & GLP-1 education
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Alan Meds and Tirzepatide: Dispensing and Program Model
Zealthy GLP-1: Program Structure, Eligibility, Pricing